These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 16044093)

  • 21. Intravenous iron sucrose versus oral iron in treatment of iron deficiency anemia in pregnancy: a randomized clinical trial.
    Kochhar PK; Kaundal A; Ghosh P
    J Obstet Gynaecol Res; 2013 Feb; 39(2):504-10. PubMed ID: 22925176
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Treatment of anaemia in inflammatory bowel disease with iron sucrose.
    Bodemar G; Kechagias S; Almer S; Danielson BG
    Scand J Gastroenterol; 2004 May; 39(5):454-8. PubMed ID: 15180183
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FERGIcor, a randomized controlled trial on ferric carboxymaltose for iron deficiency anemia in inflammatory bowel disease.
    Evstatiev R; Marteau P; Iqbal T; Khalif IL; Stein J; Bokemeyer B; Chopey IV; Gutzwiller FS; Riopel L; Gasche C;
    Gastroenterology; 2011 Sep; 141(3):846-853.e1-2. PubMed ID: 21699794
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ferumoxytol: an intravenous iron, riskier than iron sucrose.
    Prescrire Int; 2013 Sep; 22(141):206. PubMed ID: 24171212
    [No Abstract]   [Full Text] [Related]  

  • 25. Use of iron sucrose injection in anemia patients with reduced serum iron concentration during hospitalizations of digestive and liver diseases.
    Hong C; Xu X; Feng R; Romeiro FG; Zhang D; Bai Z; Guo X; Qi X
    Ann Palliat Med; 2021 Feb; 10(2):1145-1153. PubMed ID: 32954752
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Proteinuria induced by parenteral iron in chronic kidney disease--a comparative randomized controlled trial.
    Agarwal R; Leehey DJ; Olsen SM; Dahl NV
    Clin J Am Soc Nephrol; 2011 Jan; 6(1):114-21. PubMed ID: 20876669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Evaluation of the efficacy and safety of intravenous infusion of ferric derisomaltose in the treatment of iron deficiency anemia: a single-center retrospective analysis].
    Ding SX; Zhao YH; Wang T; Guan J; Xing LM; Liu H; Wang GJ; Wang XM; Wu YH; Qu W; Song J; Wang HQ; Li LJ; Shao ZH; Fu R
    Zhonghua Xue Ye Xue Za Zhi; 2024 Feb; 45(2):178-183. PubMed ID: 38604795
    [No Abstract]   [Full Text] [Related]  

  • 28. Intravenous iron sucrose: an alternative for oral iron in pregnancy with iron deficiency anemia.
    Shi Q; Li J; Yao Q; Mi C; Yang J; Xing A
    Ann Hematol; 2015 Mar; 94(3):523-5. PubMed ID: 25123238
    [No Abstract]   [Full Text] [Related]  

  • 29. Fibroblast growth factor 23-related osteomalacia caused by the prolonged administration of saccharated ferric oxide.
    Yamamoto S; Okada Y; Mori H; Fukumoto S; Tanaka Y
    Intern Med; 2012; 51(17):2375-8. PubMed ID: 22975552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical case reports raise doubts about the therapeutic equivalence of an iron sucrose similar preparation compared with iron sucrose originator.
    Stein J; Dignass A; Chow KU
    Curr Med Res Opin; 2012 Feb; 28(2):241-3. PubMed ID: 22181342
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding.
    Schröder O; Schrott M; Blumenstein I; Jahnel J; Dignass AU; Stein J
    Z Gastroenterol; 2004 Aug; 42(8):663-7. PubMed ID: 15314711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fatal anaphylactic reaction to iron sucrose in pregnancy.
    Mishra A; Dave N; Viradiya K
    Indian J Pharmacol; 2013; 45(1):93-4. PubMed ID: 23543624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of intravenous iron sucrose in children younger than 2 years with intestinal failure.
    Lepus CA; Samela K; Mokha JS
    Nutr Clin Pract; 2023 Aug; 38(4):899-903. PubMed ID: 36440796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A case of hypophosphatemia induced by intravenous administration of saccharated iron oxide].
    Konjiki O; Fukaya S; Kanou H; Imamura T; Iwamoto T; Takasaki M
    Nihon Ronen Igakkai Zasshi; 1994 Oct; 31(10):805-10. PubMed ID: 7853746
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Should intravenous iron be upfront therapy for iron deficiency anemia?
    Auerbach M
    Pediatr Blood Cancer; 2011 Apr; 56(4):511-2. PubMed ID: 21298731
    [No Abstract]   [Full Text] [Related]  

  • 36. Chronic use of sodium ferric gluconate complex in hemodialysis patients: safety of higher-dose (> or =250 mg) administration.
    Folkert VW; Michael B; Agarwal R; Coyne DW; Dahl N; Myirski P; Warnock DG;
    Am J Kidney Dis; 2003 Mar; 41(3):651-7. PubMed ID: 12612989
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative rates of adverse events with different formulations of intravenous iron.
    Okam MM; Mandell E; Hevelone N; Wentz R; Ross A; Abel GA
    Am J Hematol; 2012 Nov; 87(11):E123-4. PubMed ID: 22965928
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Review of available intravenous iron preparations in hemodialysis.
    Palmer K; Cameron K; Battistella M
    CANNT J; 2013; 23(2):51-4; quiz 55-6. PubMed ID: 24069699
    [No Abstract]   [Full Text] [Related]  

  • 39. Safety and efficacy of intravenous iron polymaltose, iron sucrose and ferric carboxymaltose in pregnancy: A systematic review.
    Qassim A; Mol BW; Grivell RM; Grzeskowiak LE
    Aust N Z J Obstet Gynaecol; 2018 Feb; 58(1):22-39. PubMed ID: 28921558
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intravenous Iron Sucrose for Children With Iron Deficiency Anemia.
    Kaneva K; Chow E; Rosenfield CG; Kelly MJ
    J Pediatr Hematol Oncol; 2017 Jul; 39(5):e259-e262. PubMed ID: 28562517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.